182 related articles for article (PubMed ID: 19956069)
1. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069
[TBL] [Abstract][Full Text] [Related]
2. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma.
Sun XF
Clin Cancer Res; 2002 Jan; 8(1):165-70. PubMed ID: 11801554
[TBL] [Abstract][Full Text] [Related]
3. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
[TBL] [Abstract][Full Text] [Related]
5. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer.
Zhang H; Sun XF
Int J Oncol; 2001 Jul; 19(1):49-52. PubMed ID: 11408921
[TBL] [Abstract][Full Text] [Related]
6. [P73 gene expression in colorectal adenocarcinoma: a prognostic or etiopathogenetic factor?].
Ben Mahmoud LK; Toumi AA; Chaâr I; Lahmer A; Khalfallah T; Mzabi SR; Bouraoui S
Tunis Med; 2009 Apr; 87(4):267-72. PubMed ID: 19835284
[TBL] [Abstract][Full Text] [Related]
7. p73 expression and its clinical significance in colorectal cancer.
Su XL; Ouyang XH; Yan MR; Liu GR
Colorectal Dis; 2009 Nov; 11(9):960-3. PubMed ID: 19016816
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
9. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
10. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
[TBL] [Abstract][Full Text] [Related]
11. Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers.
Masuda N; Kato H; Nakajima T; Sano T; Kashiwabara K; Oyama T; Kuwano H
Cancer Sci; 2003 Jul; 94(7):612-7. PubMed ID: 12841870
[TBL] [Abstract][Full Text] [Related]
12. Expression of p73 in colorectal carcinoma: clinicopathological relevance.
Liu L; Cui X; Sakaguchi T; Sasaki M; Suda T; Hatakeyama K
J Int Med Res; 2001; 29(4):297-303. PubMed ID: 11675903
[TBL] [Abstract][Full Text] [Related]
13. Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.
Becker K; Pancoska P; Concin N; Vanden Heuvel K; Slade N; Fischer M; Chalas E; Moll UM
Int J Oncol; 2006 Oct; 29(4):889-902. PubMed ID: 16964385
[TBL] [Abstract][Full Text] [Related]
14. p53 and p73 expression in esophageal carcinoma correlate with clinicopathology of tumors.
Ye B; Wang X; Yang Z; Sun Z; Zhang R; Hu Y; Lu Y; Du J
Hepatogastroenterology; 2012 Oct; 59(119):2192-5. PubMed ID: 22534503
[TBL] [Abstract][Full Text] [Related]
15. Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer.
Saavedra K; Valbuena J; Olivares W; Marchant MJ; Rodríguez A; Torres-Estay V; Carrasco-Avino G; Guzmán L; Aguayo F; Roa JC; Corvalán AH
PLoS One; 2015; 10(5):e0125834. PubMed ID: 25954972
[TBL] [Abstract][Full Text] [Related]
16. Role of p73 in malignancy: tumor suppressor or oncogene?
Stiewe T; Pützer BM
Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
[TBL] [Abstract][Full Text] [Related]
17. Relationship between p73 polymorphism and the immunohistochemical profile of the full-length (TAp73) and NH2-truncated (ΔNp73) isoforms in Tunisian patients.
Arfaoui AT; Ben Mahmoud LK; Ben Hmida A; Khiari M; Mohamed AL; Chaar I; Khalfallah T; Regaya SM; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):546-54. PubMed ID: 20733477
[TBL] [Abstract][Full Text] [Related]
18. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
[TBL] [Abstract][Full Text] [Related]
19. p73 Overexpression and angiogenesis in human colorectal carcinoma.
Guan M; Peng HX; Yu B; Lu Y
Jpn J Clin Oncol; 2003 May; 33(5):215-20. PubMed ID: 12865464
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]